Search Results - "MYELOFIBROSIS"

Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 study.

Authors: Kiladjian JJ Borate U Abruzzese E et al.

Source: The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7).

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors.

Authors: Al Noumani I Harrison C

Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 Jun; Vol. 27 (8), pp. 657-668. Date of Electronic Publication: 2026 May 12.

Publication Type: Journal Article; Review

Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review.

Authors: Yin HQ Jin S Fu Y et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 14; Vol. 17, pp. 1685536. Date of Electronic Publication: 2026 May 14 (Print Publication: 2026).

Publication Type: Journal Article; Case Reports; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis.

Authors: Zielińska P Wieczorkiewicz-Kabut A Spałek A et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2026 May 14; Vol. 26 (1). Date of Electronic Publication: 2026 May 14.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Authors: De Fazio L Molica M Simio C et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 May; Vol. 67 (6), pp. 1257-1267. Date of Electronic Publication: 2026 Apr 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Authors: Rampotas A Wong ZC Gannon I et al.

Source: Science translational medicine [Sci Transl Med] 2026 Jul; Vol. 18 (856), pp. eadz3553. Date of Electronic Publication: 2026 Jul 01.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges.

Authors: Maltese T Raffa G Stagno F et al.

Source: Journal of clinical laboratory analysis [J Clin Lab Anal] 2026 Jun; Vol. 40 (11), pp. e70201. Date of Electronic Publication: 2026 May 13.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 8801384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2825 (Electronic) Linking ISSN: 08878013 NLM ISO Abbreviation: J Clin Lab Anal Subsets: MEDLINE

Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan.

Authors: Yasutomi Y Takano M Chen YC et al.

Source: PloS one [PLoS One] 2026 May 08; Vol. 21 (5), pp. e0348598. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Ruxolitinib and heart failure outcomes among patients with myelofibrosis.

Authors: Leiva O Soo S Liu OC et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 May; Vol. 67 (6), pp. 1335-1342. Date of Electronic Publication: 2026 Mar 05.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Ruxolitinib treatment for myelofibrosis with anemia: a retrospective assessment of real-world patient characteristics, treatment patterns, and survival.

Authors: Kuykendall AT Palandri F Fillbrunn M et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Apr; Vol. 67 (5), pp. 1088-1099. Date of Electronic Publication: 2026 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Authors: Gagnon LL Harrison CN

Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 Apr; Vol. 27 (5), pp. 439-450. Date of Electronic Publication: 2026 Apr 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

Integrated transcriptome-proteome analysis in patients with myelofibrosis-related anemia.

Authors: Yang L Chen Y Wu Y

Source: Annals of hematology [Ann Hematol] 2026 Mar 28; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 28.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

MPIG6B-related thrombocytopenia and myelofibrosis: A case report.

Authors: Wang X Xue F Zhang L et al.

Source: Annals of hematology [Ann Hematol] 2026 Mar 16; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 16.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.

Authors: Palandri F Kapetanakis V Dobi B et al.

Source: Annals of hematology [Ann Hematol] 2026 Feb 21; Vol. 105 (4). Date of Electronic Publication: 2026 Feb 21.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.

Authors: Lanamtieng T Mervaala-Muroke A Toivanen L et al.

Source: Annals of hematology [Ann Hematol] 2026 Feb 06; Vol. 105 (3), pp. 94. Date of Electronic Publication: 2026 Feb 06.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Deciphering the role of HMGA2 and let-7 microRNAs in myelodysplastic neoplasms with bone marrow fibrosis.

Authors: Vlachopoulou D Kontandreopoulou CN Diamantopoulos PT et al.

Corporate Authors: Vlachopoulou D Kontandreopoulou CN Diamantopoulos PT et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Apr; Vol. 67 (5), pp. 1109-1115. Date of Electronic Publication: 2026 Feb 24.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

[Cutaneous Cryptococcus neoformans Infection Mimicking Necrotizing Fasciitis in a Myelofibrosis Patient Receiving Ruxolitinib: A Case Report].

Transliterated Title: Ruksolitinib Kullanan Miyelofibrozis Hastasında Nekrotizan Fasiiti Taklit Eden Kutanöz Cryptococcus neoformans Enfeksiyonu: Bir Olgu Sunumu.

Authors: Kuruoğlu T Karaçeşme TS Ekmekçi Kurt S et al.

Source: Mikrobiyoloji bulteni [Mikrobiyol Bul] 2026 Apr; Vol. 60 (2), pp. 227-236.

Publication Type: Case Reports; Journal Article; English Abstract

Journal Info: Publisher: Ankara Mikrobiyoloji Dernegi Country of Publication: Turkey NLM ID: 7503830 Publication Model: Print Cited Medium: Print ISSN: 0374-9096 (Print) Linking ISSN: 03749096 NLM ISO Abbreviation: Mikrobiyol Bul Subsets: MEDLINE

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis.

Authors: O'Sullivan J Omerdeen I Psaila B

Source: British journal of haematology [Br J Haematol] 2026 Feb; Vol. 208 (2), pp. 437-441. Date of Electronic Publication: 2024 Nov 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Acute psychosis following initiation of ruxolitinib in post-polycythaemia vera myelofibrosis case report.

Authors: Potter LJ Shetty S Ceesay MM

Source: Annals of hematology [Ann Hematol] 2026 Jan 23; Vol. 105 (2), pp. 53. Date of Electronic Publication: 2026 Jan 23.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms.

Authors: Demoy M Bauvais M Vely A et al.

Source: Annals of hematology [Ann Hematol] 2026 Jan 16; Vol. 105 (1), pp. 21. Date of Electronic Publication: 2026 Jan 16.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE